FTC approves Schick deal
This article was originally published in The Rose Sheet
Executive Summary
Purchase of Pfizer's Schick-Wilkinson Sword razor business by Energizer Holdings approved by FTC, anti-trust enforcers announce Feb. 19. Battery manufacturer recently revealed plan to purchase the business from Pfizer for $930 mil. in a transaction expected to close in the spring (1"The Rose Sheet" Jan. 27, 2003, p. 4). Move will expand Energizer's business beyond batteries and improve its competitive position vis-à-vis Duracell battery manufacturer Gillette, which currently dominates the shaving market with a 70% share...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.